{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:00:30Z","timestamp":1787162430969,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172766"],"award-info":[{"award-number":["82172766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-025-04821-0","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:18:07Z","timestamp":1739877487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dissecting the rising tide of inflammatory bowel disease among youth in a changing world: insights from GBD 2021"],"prefix":"10.1007","volume":"40","author":[{"given":"Libin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shourong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"4821_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","volume":"169","author":"MJ Rosen","year":"2015","unstructured":"Rosen MJ, Dhawan A, Saeed SA (2015) Inflammatory bowel disease in children and adolescents. JAMA Pediatr 169:1053\u20131060. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.1982","journal-title":"JAMA Pediatr"},{"key":"4821_CR2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769\u20132778. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"4821_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41395-018-0233-2","volume":"114","author":"SC Ng","year":"2019","unstructured":"Ng SC et al (2019) Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol 114:107\u2013115. https:\/\/doi.org\/10.1038\/s41395-018-0233-2","journal-title":"Am J Gastroenterol"},{"key":"4821_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cgh.2019.06.030","volume":"18","author":"PG Kotze","year":"2020","unstructured":"Kotze PG et al (2020) Progression of inflammatory bowel diseases throughout Latin America and the Caribbean: a systematic review. Clin Gastroenterol Hepatol 18:304\u2013312. https:\/\/doi.org\/10.1016\/j.cgh.2019.06.030","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4821_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12876-021-01745-1","volume":"21","author":"M Olfatifar","year":"2021","unstructured":"Olfatifar M et al (2021) The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: a modeling study. BMC Gastroenterol 21:204. https:\/\/doi.org\/10.1186\/s12876-021-01745-1","journal-title":"BMC Gastroenterol"},{"key":"4821_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2021.12.282","volume":"162","author":"ME Kuenzig","year":"2022","unstructured":"Kuenzig ME et al (2022) Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology 162:1147-1159.e1144. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.282","journal-title":"Gastroenterology"},{"key":"4821_CR7","doi-asserted-by":"publisher","unstructured":"Molodecky NA et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142. https:\/\/doi.org\/10.1053\/j.gastro.2011.10.001","DOI":"10.1053\/j.gastro.2011.10.001"},{"key":"4821_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ibd.21007","volume":"16","author":"D Duricova","year":"2010","unstructured":"Duricova D et al (2010) Overall and cause-specific mortality in Crohn\u2019s disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 16:347\u2013353. https:\/\/doi.org\/10.1002\/ibd.21007","journal-title":"Inflamm Bowel Dis"},{"key":"4821_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park KT et al (2020) The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation. Inflamm Bowel Dis 26:1\u201310. https:\/\/doi.org\/10.1093\/ibd\/izz104","journal-title":"Inflamm Bowel Dis"},{"key":"4821_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ibd\/izac144","volume":"29","author":"P Holko","year":"2023","unstructured":"Holko P, Kawalec P, Sajak-Szczerba M, Avedano L, Mossakowska M (2023) Indirect costs of inflammatory bowel diseases: a comparison of patient-reported outcomes across 12 European countries. Inflamm Bowel Dis 29:752\u2013762. https:\/\/doi.org\/10.1093\/ibd\/izac144","journal-title":"Inflamm Bowel Dis"},{"key":"4821_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(18)30323-4","volume":"391","author":"S Jan","year":"2018","unstructured":"Jan S et al (2018) Action to address the household economic burden of non-communicable diseases. Lancet 391:2047\u20132058. https:\/\/doi.org\/10.1016\/S0140-6736(18)30323-4","journal-title":"Lancet"},{"key":"4821_CR12","doi-asserted-by":"publisher","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019 (2020). Lancet 396:1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"4821_CR13","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019 (2021). Lancet Neurol 20:795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"4821_CR14","doi-asserted-by":"publisher","unstructured":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019 (2020). Lancet 396:1223\u20131249. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"4821_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307\u2013317. https:\/\/doi.org\/10.1038\/nature10209","journal-title":"Nature"},{"key":"4821_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S2468-1253(22)00337-5","volume":"8","author":"J Kammermeier","year":"2023","unstructured":"Kammermeier J et al (2023) Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology. Hepatol Nutr Lancet Gastroenterol Hepatol 8:271\u2013286. https:\/\/doi.org\/10.1016\/S2468-1253(22)00337-5","journal-title":"Hepatol Nutr Lancet Gastroenterol Hepatol"},{"key":"4821_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z et al (2019) The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol 70:674\u2013683. https:\/\/doi.org\/10.1016\/j.jhep.2018.12.001","journal-title":"J Hepatol"},{"key":"4821_CR18","doi-asserted-by":"publisher","unstructured":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021 (2024). Lancet 403:2162\u20132203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4","DOI":"10.1016\/S0140-6736(24)00933-4"},{"key":"4821_CR19","doi-asserted-by":"publisher","first-page":"994619","DOI":"10.3389\/fpubh.2022.994619","volume":"10","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Long-term trends in the burden of inflammatory bowel disease in China over three decades: a joinpoint regression and age-period-cohort analysis based on GBD 2019. Front Public Health 10:994619. https:\/\/doi.org\/10.3389\/fpubh.2022.994619","journal-title":"Front Public Health"},{"key":"4821_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335\u2013351","journal-title":"Stat Med"},{"key":"4821_CR21","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1002\/sim.6248","volume":"33","author":"V J\u00fcrgens","year":"2014","unstructured":"J\u00fcrgens V, Ess S, Cerny T, Vounatsou P (2014) A Bayesian generalized age-period-cohort power model for cancer projections. Stat Med 33:4627\u20134636. https:\/\/doi.org\/10.1002\/sim.6248","journal-title":"Stat Med"},{"key":"4821_CR22","doi-asserted-by":"publisher","first-page":"103498","DOI":"10.1016\/j.autrev.2023.103498","volume":"23","author":"S Wang","year":"2024","unstructured":"Wang S, Dong Z, Wan X (2024) Global, regional, and national burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: an analysis of the global burden of disease study 2019. Autoimmun Rev 23:103498. https:\/\/doi.org\/10.1016\/j.autrev.2023.103498","journal-title":"Autoimmun Rev"},{"key":"4821_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00384-024-04711-x","volume":"39","author":"D Lin","year":"2024","unstructured":"Lin D et al (2024) Global, regional, and national burden of inflammatory bowel disease, 1990\u20132021: insights from the global burden of disease 2021. Int J Colorectal Dis 39:139. https:\/\/doi.org\/10.1007\/s00384-024-04711-x","journal-title":"Int J Colorectal Dis"},{"key":"4821_CR24","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S (2024) Crohn\u2019s disease. Lancet 403:1177\u20131191. https:\/\/doi.org\/10.1016\/S0140-6736(23)02586-2","journal-title":"Lancet"},{"key":"4821_CR25","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.dld.2023.04.003","volume":"55","author":"J Park","year":"2023","unstructured":"Park J et al (2023) The global, regional, and national burden of inflammatory bowel diseases, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Dig Liver Dis 55:1352\u20131359. https:\/\/doi.org\/10.1016\/j.dld.2023.04.003","journal-title":"Dig Liver Dis"},{"key":"4821_CR26","doi-asserted-by":"publisher","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, Li Z, Liu S, Zhang D (2023) Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open 13:e065186. https:\/\/doi.org\/10.1136\/bmjopen-2022-065186","journal-title":"BMJ Open"},{"key":"4821_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10880-019-09649-9","volume":"27","author":"L Stapersma","year":"2020","unstructured":"Stapersma L et al (2020) Psychological outcomes of a cognitive behavioral therapy for youth with inflammatory bowel disease: results of the HAPPY-IBD randomized controlled trial at 6- and 12-month follow-up. J Clin Psychol Med Settings 27:490\u2013506. https:\/\/doi.org\/10.1007\/s10880-019-09649-9","journal-title":"J Clin Psychol Med Settings"},{"key":"4821_CR28","doi-asserted-by":"publisher","unstructured":"Suskind dl et al (2020) The specific carbohydrate diet and diet modification as induction therapy for pediatric Crohn\u2019s disease: a randomized diet controlled trial. Nutrients 12. https:\/\/doi.org\/10.3390\/nu12123749","DOI":"10.3390\/nu12123749"},{"key":"4821_CR29","doi-asserted-by":"publisher","first-page":"110594","DOI":"10.1016\/j.jpsychores.2021.110594","volume":"149","author":"T Ewais","year":"2021","unstructured":"Ewais T et al (2021) Mindfulness based cognitive therapy for youth with inflammatory bowel disease and depression - findings from a pilot randomised controlled trial. J Psychosom Res 149:110594. https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110594","journal-title":"J Psychosom Res"},{"key":"4821_CR30","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1053\/j.gastro.2021.02.068","volume":"160","author":"S Schreiber","year":"2021","unstructured":"Schreiber S et al (2021) Randomized controlled trial: subcutaneous vs intravenous infliximab CT-P13 maintenance in inflammatory bowel disease. Gastroenterology 160:2340\u20132353. https:\/\/doi.org\/10.1053\/j.gastro.2021.02.068","journal-title":"Gastroenterology"},{"key":"4821_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gutjnl-2020-322339","volume":"71","author":"MME Jongsma","year":"2022","unstructured":"Jongsma MME et al (2022) First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn\u2019s disease: an open-label multicentre randomised controlled trial. Gut 71:34\u201342. https:\/\/doi.org\/10.1136\/gutjnl-2020-322339","journal-title":"Gut"},{"key":"4821_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S2468-1253(22)00358-2","volume":"8","author":"S Singh","year":"2023","unstructured":"Singh S, Boland BS, Jess T, Moore AA (2023) Management of inflammatory bowel diseases in older adults. Lancet Gastroenterol Hepatol 8:368\u2013382. https:\/\/doi.org\/10.1016\/S2468-1253(22)00358-2","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4821_CR33","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.cgh.2020.08.053","volume":"19","author":"LA Shafer","year":"2021","unstructured":"Shafer LA et al (2021) An international multicenter comparison of IBD-related disability and validation of the IBDDI. Clin Gastroenterol Hepatol 19:2524\u20132531. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.053","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4821_CR34","doi-asserted-by":"publisher","unstructured":"Xu L et al (2023) Incidence of inflammatory bowel disease in urban China: a\u00a0nationwide population-based study. Clin Gastroenterol Hepatol 21. https:\/\/doi.org\/10.1016\/j.cgh.2023.08.013","DOI":"10.1016\/j.cgh.2023.08.013"},{"key":"4821_CR35","doi-asserted-by":"publisher","first-page":"n1554","DOI":"10.1136\/bmj.n1554","volume":"374","author":"N Narula","year":"2021","unstructured":"Narula N et al (2021) Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ 374:n1554. https:\/\/doi.org\/10.1136\/bmj.n1554","journal-title":"BMJ"},{"key":"4821_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41575-018-0003-z","volume":"15","author":"T Zuo","year":"2018","unstructured":"Zuo T, Kamm MA, Colombel J-F, Ng SC (2018) Urbanization and the gut microbiota in health and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 15:440\u2013452. https:\/\/doi.org\/10.1038\/s41575-018-0003-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4821_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW (2021) The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 18:56\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00360-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4821_CR38","doi-asserted-by":"publisher","unstructured":"Nguyen NH, Khera R, Ohno-Machado L, Sandborn WJ, Singh S (2021) Prevalence and effects of food insecurity and social support on financial toxicity in and healthcare use by patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 19. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.056","DOI":"10.1016\/j.cgh.2020.05.056"},{"key":"4821_CR39","doi-asserted-by":"publisher","unstructured":"Lewis JD et al (2023) Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology 165. https:\/\/doi.org\/10.1053\/j.gastro.2023.07.003","DOI":"10.1053\/j.gastro.2023.07.003"},{"key":"4821_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.06.052","author":"V Chedid","year":"2024","unstructured":"Chedid V, Targownik L, Damas OM, Balzora S (2024) Culturally-sensitive and inclusive IBD care. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2024.06.052","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04821-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-04821-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04821-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:18:10Z","timestamp":1739877490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-04821-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4821"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-04821-0","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"3 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data analyzed in this study is publicly available from existing, published Global Burden of Disease (GBD) study from 1990 to 2021. Therefore, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}